Literature DB >> 2071825

Role of growth hormone-releasing hormone on pentagastrin-induced growth hormone release in normal subjects.

J F Garcia-Rojas1, A Mangas, A Barba, J Millan, C Dieguez, E Zamora.   

Abstract

In order to investigate the mechanisms by which gastrin cause GH release in humans we measured the GH response to pentagastrin alone (1.5 micrograms/kg/hour from 120 to 210 min) and following pretreatment with GHRH (GHRH 1-29,250 micrograms, iv at 0 min) in normal male subjects. Prior GHRH administration abolished the GH response to the second bolus of GHRH (1 micrograms/kg) administered two hours later. Pentagastrin infusion induced a rise in GH levels maximal at 60 min (9.1 + 0.6 ng/ml, mean + SE), but this rise was abolished by pretreatment with GHRH. Finally, we found that gastrin did not modify basal GH release or GH responses to GHRH by rat anterior pituitary cells in monolayer culture. Taken together, these data suggest that gastrin regulates GH secretion by acting at hypothalamic level.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2071825     DOI: 10.1007/BF03346800

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

Review 1.  The expression of progastrin, procholecystokinin and their hormonal products in pituitary cells.

Authors:  J F Rehfeld
Journal:  J Mol Endocrinol       Date:  1988-09       Impact factor: 5.098

Review 2.  Neural control of somatotropic function.

Authors:  E E Müller
Journal:  Physiol Rev       Date:  1987-07       Impact factor: 37.312

3.  Alpha-2-adrenergic pathways release growth hormone via a non-GRF-dependent mechanism in normal human subjects.

Authors:  R Valcavi; C Dieguez; M D Page; M Zini; P Casoli; I Portioli; M F Scanlon
Journal:  Clin Endocrinol (Oxf)       Date:  1988-09       Impact factor: 3.478

4.  Effects of intraventricular injection of gastrin on release of LH, prolactin, TSH and GH in conscious ovariectomized rats.

Authors:  E Vijayan; W K Samson; S M McCann
Journal:  Life Sci       Date:  1978-11-27       Impact factor: 5.037

5.  Growth hormone secretion and pentagastrin.

Authors:  W Domschke; G Lux; S Domschke
Journal:  N Engl J Med       Date:  1980-08-21       Impact factor: 91.245

6.  Stimulation of somatostatin release in vitro by synthetic human growth hormone-releasing factor by a nondopaminergic mechanism.

Authors:  M C Aguila; S M McCann
Journal:  Endocrinology       Date:  1985-08       Impact factor: 4.736

7.  Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro.

Authors:  P Brazeau; N Ling; P Böhlen; F Esch; S Y Ying; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

8.  Plasma GH responses to GHRH and insulin-induced hypoglycemia in man.

Authors:  T Shibasaki; M Hotta; A Masuda; T Imaki; N Obara; H Demura; N Ling; K Shizume
Journal:  J Clin Endocrinol Metab       Date:  1985-06       Impact factor: 5.958

9.  Growth hormone (GH) responses to arginine and L-dopa alone and after GHRH pretreatment.

Authors:  M D Page; C Dieguez; R Valcavi; C Edwards; R Hall; M F Scanlon
Journal:  Clin Endocrinol (Oxf)       Date:  1988-05       Impact factor: 3.478

10.  The effects of thyroid hormone deprivation in vivo and in vitro on growth hormone (GH) responses to human pancreatic (tumor) GH-releasing factor (1-40) by dispersed rat anterior pituitary cells.

Authors:  C Dieguez; S M Foord; J R Peters; R Hall; M F Scanlon
Journal:  Endocrinology       Date:  1985-03       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.